BRCA2 and male breast carcinoma: Male Breast Carcinoma (MBC) is a relatively rare malignant disease, and accounts for about less than 1% of all breast carcinomas, and 0.2% of all malignancies in males.1,2 Approximately 1.2 cases are affected in 100,000 males,3 and are associated with mutation of BRCA1 and BRCA2 genes, with BRCA2 mutation being the most common.4